Lucas Guillo

692 total citations
17 papers, 318 citations indexed

About

Lucas Guillo is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Lucas Guillo has authored 17 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Lucas Guillo's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (7 papers) and Autoimmune and Inflammatory Disorders (6 papers). Lucas Guillo is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (7 papers) and Autoimmune and Inflammatory Disorders (6 papers). Lucas Guillo collaborates with scholars based in France, Italy and Norway. Lucas Guillo's co-authors include Laurent Peyrin‐Biroulet, Silvio Danese, Ferdinando D’Amico, Valérie Laurent, Sophie Geyl, Cédric Baumann, Mélanie Serrero, K. Angioï, Patrick Netter and Ernest Choy and has published in prestigious journals such as Clinical Gastroenterology and Hepatology, Stem Cell Research & Therapy and Journal of Clinical Medicine.

In The Last Decade

Lucas Guillo

17 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas Guillo France 10 252 203 116 30 29 17 318
Clotilde Baudry France 6 282 1.1× 238 1.2× 120 1.0× 62 2.1× 19 0.7× 9 335
M. Ascolani Italy 10 234 0.9× 154 0.8× 126 1.1× 63 2.1× 48 1.7× 20 323
Ana Rita Gonçalves Portugal 9 283 1.1× 227 1.1× 124 1.1× 78 2.6× 24 0.8× 28 374
Sónia Bernardo Portugal 6 260 1.0× 223 1.1× 109 0.9× 47 1.6× 13 0.4× 26 300
Katja Rothfuss Germany 6 158 0.6× 157 0.8× 92 0.8× 36 1.2× 36 1.2× 8 310
Yoon‐Kyo An Australia 9 224 0.9× 179 0.9× 140 1.2× 53 1.8× 9 0.3× 24 329
N. Scaglione Italy 6 284 1.1× 225 1.1× 125 1.1× 44 1.5× 13 0.4× 7 365
Ágnes Horváth Hungary 7 321 1.3× 273 1.3× 134 1.2× 45 1.5× 10 0.3× 12 360
Diana Whitehead United States 4 213 0.8× 186 0.9× 119 1.0× 52 1.7× 11 0.4× 10 276
Alessandra Losco Italy 8 123 0.5× 72 0.4× 129 1.1× 19 0.6× 21 0.7× 12 240

Countries citing papers authored by Lucas Guillo

Since Specialization
Citations

This map shows the geographic impact of Lucas Guillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Guillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Guillo more than expected).

Fields of papers citing papers by Lucas Guillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Guillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Guillo. The network helps show where Lucas Guillo may publish in the future.

Co-authorship network of co-authors of Lucas Guillo

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Guillo. A scholar is included among the top collaborators of Lucas Guillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Guillo. Lucas Guillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Guillo, Lucas, Mélanie Velier, Mélanie Serrero, et al.. (2025). Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn’s disease: a systematic review and meta-analysis. Stem Cell Research & Therapy. 16(1). 152–152. 4 indexed citations
2.
3.
Guillo, Lucas, Fanny Grimaud, Élisabeth Jouve, et al.. (2022). Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn’s disease. Stem Cell Research & Therapy. 13(1). 67–67. 13 indexed citations
4.
D’Amico, Ferdinando, Gionata Fiorino, Virginia Solitano, et al.. (2022). Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study. United European Gastroenterology Journal. 10(7). 775–782. 27 indexed citations
5.
Guillo, Lucas, Cédric Baumann, Patrick Netter, et al.. (2022). Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era. Journal of Clinical Medicine. 11(15). 4538–4538. 11 indexed citations
6.
Guillo, Lucas, Guillaume Bonnaud, Stéphane Nahon, et al.. (2022). French experience with telemedicine in inflammatory bowel disease: a patients and physicians survey.. European Journal of Gastroenterology & Hepatology. 34(4). 398–404. 4 indexed citations
7.
D’Amico, Ferdinando, Lucas Guillo, Cédric Baumann, Silvio Danese, & Laurent Peyrin‐Biroulet. (2021). Histological Disease Activity Measured by the Nancy Index Is Associated with Long-term Outcomes in Patients with Ulcerative Colitis. Journal of Crohn s and Colitis. 15(10). 1631–1640. 22 indexed citations
8.
Guillo, Lucas, Ferdinando D’Amico, Carole Ayav, et al.. (2021). Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know. Digestive and Liver Disease. 53(6). 691–696. 13 indexed citations
9.
Guillo, Lucas, Ferdinando D’Amico, Patrick Netter, et al.. (2021). Incidence of and Risk Factors for Colorectal Strictures in Ulcerative Colitis: A Multicenter Study. Clinical Gastroenterology and Hepatology. 19(9). 1899–1905.e1. 14 indexed citations
10.
Geyl, Sophie, Lucas Guillo, Valérie Laurent, et al.. (2021). Transmural healing as a therapeutic goal in Crohn's disease: a systematic review. ˜The œLancet. Gastroenterology & hepatology. 6(8). 659–667. 94 indexed citations
11.
D’Amico, Ferdinando, Gionata Fiorino, Virginia Solitano, et al.. (2021). DOP87 Disease clearance as a new therapeutic target in patients with Ulcerative Colitis: A multicenter retrospective cohort study. Journal of Crohn s and Colitis. 15(Supplement_1). S118–S119. 2 indexed citations
12.
Guillo, Lucas, Guillaume Bonnaud, Stéphane Nahon, et al.. (2021). French experience with telemedicine in inflammatory bowel disease: a patients and physicians survey. European Journal of Gastroenterology & Hepatology. 34(4). 398–404. 4 indexed citations
13.
Guillo, Lucas, Ferdinando D’Amico, Silvio Danese, & Laurent Peyrin‐Biroulet. (2020). Ustekinumab for Extra-intestinal Manifestations of Inflammatory Bowel Disease: A Systematic Literature Review. Journal of Crohn s and Colitis. 15(7). 1236–1243. 62 indexed citations
14.
Guillo, Lucas, Ferdinando D’Amico, Mélanie Serrero, et al.. (2020). Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials. United European Gastroenterology Journal. 8(9). 1013–1030. 19 indexed citations
15.
Guillo, Lucas, Ferdinando D’Amico, Adeline Germain, et al.. (2020). Predictors for short bowel syndrome in Crohn's disease. Digestive and Liver Disease. 52(12). 1455–1460. 5 indexed citations
16.
Guillo, Lucas, Christian Rabaud, Ernest Choy, et al.. (2020). Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide. Clinical Gastroenterology and Hepatology. 20(3). 481–490. 18 indexed citations
17.
Guillo, Lucas, Ferdinando D’Amico, Silvio Danese, et al.. (2020). Knowledge of 5-aminosalicylic acid nephrotoxicity and adherence to kidney function monitoring of patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 33(9). 1148–1152. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clotilde Baudry Breakdown of academic impact, for papers by M. Ascolani Breakdown of academic impact, for papers by Ana Rita Gonçalves Breakdown of academic impact, for papers by Sónia Bernardo Breakdown of academic impact, for papers by Katja Rothfuss Breakdown of academic impact, for papers by Yoon‐Kyo An Breakdown of academic impact, for papers by N. Scaglione Breakdown of academic impact, for papers by Ágnes Horváth Breakdown of academic impact, for papers by Diana Whitehead Breakdown of academic impact, for papers by Alessandra Losco
Rankless by CCL
2026